In silico validation of a new classifier, PCSCGier, for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets

In silico validation of a new classifier, PCSCGier, for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets

Bibliographic Details
Main Authors:	Meng Zhang, Zichen Bian, Jia Chen, Lei Chen, Jun Zhou, Qingsong Niu, Zongyao Hao, Jialin Meng, Chaozhao Liang
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.1105

Similar Items

Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
by: Cheng Yang, et al.
Published: (2022-12-01)

Nomogram for predicting the overall survival of patients with early‐onset prostate cancer: A population‐based retrospective study
by: Yongtao Hu, et al.
Published: (2022-09-01)

The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer
by: Jialin Meng, et al.
Published: (2019-09-01)

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
by: Qintao Ge, et al.
Published: (2023-12-01)

EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort
by: Qintao Ge, et al.
Published: (2022-09-01)

Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction
by: Qintao Ge, et al.
Published: (2024-01-01)

Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review
by: Jialin Meng, et al.
Published: (2018-10-01)

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
by: Zichen Bian, et al.
Published: (2023-01-01)

Integrated multi‐omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer
by: Jialin Meng, et al.
Published: (2021-12-01)

Overexpression of DDX49 in prostate cancer is associated with poor prognosis
by: Junyue Tao, et al.
Published: (2023-04-01)

Establishment of an age‐ and tumor microenvironment‐related gene signature for survival prediction in prostate cancer
by: Lei Chen, et al.
Published: (2022-11-01)

A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study
by: Yongtao Hu, et al.
Published: (2022-10-01)

Risk subtyping and prognostic assessment of prostate cancer based on consensus genes
by: Jialin Meng, et al.
Published: (2022-03-01)

Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
by: Chun Li, et al.
Published: (2022-05-01)

HA/CD44 Regulates the T Helper 1 Cells Differentiation by Activating Annexin A1/Akt/mTOR Signaling to Drive the Pathogenesis of EAP
by: Jing Chen, et al.
Published: (2022-05-01)

Metabolomics Analysis Reveals the Differential Metabolites and Establishes the Therapeutic Effect Prediction Nomogram Among CP/CPPS Patients Who Respond or Do Not Respond to LiST
by: Jialin Meng, et al.
Published: (2022-07-01)

Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy
by: Qiang Su, et al.
Published: (2021-09-01)

A Clinicogenetic Prognostic Classifier for Prediction of Recurrence and Survival in Asian Breast Cancer Patients
by: Ting-Hao Chen, et al.
Published: (2021-03-01)

Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer
by: Sung-Woo Park, et al.
Published: (2020-12-01)

Preoperative Predictors of Biochemical Recurrence-Free Survival in High-Risk Prostate Cancer Following Radical Prostatectomy
by: Gerard Nkengurutse, et al.
Published: (2020-09-01)

Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment
by: Rui Zhou, et al.
Published: (2021-09-01)

Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients
by: Yiqiao Zhao, et al.
Published: (2022-03-01)

Hypoxia classifier for transcriptome datasets
by: Laura Puente-Santamaría, et al.
Published: (2022-05-01)

GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer
by: Ming Yang, et al.
Published: (2022-10-01)

Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019
by: Feixiang Yang, et al.
Published: (2024-09-01)

Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients
by: Cai J, et al.
Published: (2021-07-01)

Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression
by: Meng Zhang, et al.
Published: (2021-09-01)

A comparison of visual discomfort experienced by surgeons in wireless versus conventional endoscopy in laparoscopic surgery
by: Hanjiang Xu, et al.
Published: (2023-06-01)

Exploring the association between caffeine intake and benign prostatic hyperplasia: results from the NHANES 2005–2008
by: Fei Zhang, et al.
Published: (2025-01-01)

A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
by: Zhi-Bin Ke, et al.
Published: (2022-01-01)

Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
by: Khazaeipour Zahra, et al.
Published: (2010-04-01)

Pathological outcomes and biochemical recurrence-free survival after radical prostatectomy for high-risk prostate cancer in the Indian population
by: Priyank Bijalwan, et al.
Published: (2018-01-01)

Association Between Twelve Polymorphisms in Five X-ray Repair Cross-complementing Genes and the Risk of Urological Neoplasms: A Systematic Review and Meta-Analysis
by: Meng Zhang, et al.
Published: (2017-04-01)

LAMP5, One of Four Genes Related to Oxidative Stress That Predict Biochemical Recurrence-Free Survival, Promotes Proliferation and Invasion in Prostate Cancer
by: Wu P, et al.
Published: (2024-11-01)

Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer
by: Bian Z, et al.
Published: (2020-09-01)

Relationship between Macrophage and Radiosensitivity in Human Primary and Recurrent Glioblastoma: In Silico Analysis with Publicly Available Datasets
by: Bum-Sup Jang, et al.
Published: (2022-01-01)

Association between aldehyde exposure and kidney stones in adults
by: Yang Chen, et al.
Published: (2022-10-01)

Clinically relevant fatigue in recurrence-free prostate cancer survivors.
by: Storey, D, et al.
Published: (2012)

COL5A2 Promotes Proliferation and Invasion in Prostate Cancer and Is One of Seven Gleason-Related Genes That Predict Recurrence-Free Survival
by: Xiaohan Ren, et al.
Published: (2021-03-01)

LAMP5, One of Four Genes Related to Oxidative Stress That Predict Biochemical Recurrence-Free Survival, Promotes Proliferation and Invasion in Prostate Cancer [Retraction]
by: Wu P, et al.
Published: (2025-03-01)